Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PYXS Pyxis Oncology > Detailed Quotes

PYXS Pyxis Oncology

Watchlist
1.590
-0.010-0.63%
Close  01/27 16:00 ET
1.5900.0000.00%
Post Mkt Price 01/27 16:00 ET
High
1.650
Open
1.610
Turnover
16.69K
Low
1.590
Pre Close
1.600
Volume
10.32K
Market Cap
55.80M
P/E(TTM)
Loss
52wk High
9.865
Shares
35.10M
P/E(Static)
Loss
52wk Low
1.100
Float Cap
29.88M
Bid/Ask %
81.82%
Historical High
19.000
Shs Float
18.79M
Volume Ratio
0.61
Historical Low
1.100
Dividend TTM
--
Div Yield TTM
--
P/B
0.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.06%
Amplitude
3.72%
Avg Price
1.618
Lot Size
1
Float Cap
29.88M
Bid/Ask %
81.82%
Historical High
19.000
Shs Float
18.79M
Volume Ratio
0.61
Historical Low
1.100
Dividend TTM
--
P/B
0.30
Dividend LFY
--
Turnover Ratio
0.06%
Amplitude
3.72%
Avg Price
1.618
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Pyxis Oncology, Inc. engages in the development of antibody therapeutics. The company was founded by David Steinberg, Shaan Gandhi, and John Flavin on June 11, 2018 and is headquartered in Cambridge, MA.
CEO: Dr. Lara S. Sullivan, M.D.
Market: NASDAQ
Listing Date: 10/08/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist